Adenosine and hemodialysis in humans

Journal of Investigative Medicine

Volumn 49, Issue 1, 2001, Pages 56-67

  Guieu, R ^a   Brunet, P ^a   Sampol, J ^a   Bechis, G ^a   Fenouillet, E ^a   Mege, J L ^a   Capo, C ^a   Vitte, J ^a   Ibrahim, Z ^a   Carrega, L ^a   Lerda, D ^a   Rochat, H ^a   Berland, Y ^a   Dussol, B ^a  

^a CNRS   (France)

Author keywords

Adenosine; Deaminase; Hemodialysis; Mononuclear cells

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; GAMMA INTERFERON; INOSINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE SYSTEM; LIQUID CHROMATOGRAPHY; MALE; MONONUCLEAR CELL;

ADA;

EID: 0035141241     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2001.34091     Document Type: Article

References (78)

1. The immune system in uremia and during its treatment
2. Presence of preactivated T cells in hemodialyzed patients: Their possible role in altered immunity
3. Effect of biocompatible membranes on neutrophil function and metabolism
4. Relationships between biocompatibility and neutrophils function in hemodialysis patients
5. Survival of patients undergoing chronic hemodialysis and renal transplantation
6. Bacteriemia infection in hemodialysis
7. Mortality in dialysis patients: Analysis of the causes of deaths
8. Epidemiological perspectives on infections in chronic dialysis patients
9. Mortality and causes of deaths in patients in end stage renal failure
10. Perspectives of hepatitis C, human immunodeficiency virus and tuberculosis infections in dialysis patients
11. Role of adenosine induced hypotension
12. Cardiovascular effects of adenosine in man: Possible clinical implications
13. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleosides phosphorylase deficiency
14. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity
15. Adenosine deaminase deficiency
16. Regulation of adenosine metabolism by 5′nucleotidases
17. The control of the metabolism and the hormonal role of adenosine
18. Adenosine and the nervous system: Pharmacological data and therapeutic perspectives
19. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs
20. Adenosine uptake, transport and metabolism in human erythrocytes
21. Adenosine metabolism in dog whole blood: Effects of dipyridamole
22. Direct association of adenosine deaminase with T cell activation antigen CD26
23. Using ultra pure water in hemodialysis delays carpal tunnel syndrome
24. Use of HPLC to measure circulating adenosine levels in migrainous patients
25. Adenosine and neuropathic pain
26. Measurement of adenosine, inosine and hypoxanthine in human plasma
27. A new method of sampling blood for measurement of plasma adenosine
28. Interaction between cyclosporin A and adenosine in kidney transplant recipients
29. Colorimetric method
30. Peripheral blood mononuclear cell adenosine deaminase activity in renal allograft recipients
31. Generalization of distribution-free confidence intervals for bioavailability ratios
32. Methods of data analysis of ambulatory blood pressure monitoring in clinical trials
33. A reduced nicotinamide adeninedinucleotide-linked kinetic assay for adenosine deaminase activity
34. Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes
35. Adenosine A1 and A2 receptors: Structure-function relationships
36. Pulmonary aspects of dialysis patients
37. Renal handing of 2′-deoxyadenosine in humans and mice
38. Simple and sensitive binding assay for measurement of adenosine using reduced S-adenosylhomocysteine hydrolase
39. Drawing serum haptoglobin levels to determine hemolysis due to use of an incorrect reprocessed dialyzer
40. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients
41. Nucleoside and nucleobase transport systems of mammalian cells
42. Cloning the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter (ei) by functional expression in a transport-deficient cell line
43. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters ENT1 and ENT2 stably expressed in nucleoside transporter deficient PK15 cells
44. Molecular identification of the equilibrative NBMPR sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells
45. Introduction aux enzymes
46. Hereditary overexpression of adenosine deaminase in erythrocytes: Studies in erythroid cell lines and transgenic mice
47. Human adenosine deaminase: Purification and subunit structure
48. Refined 2.5 A structure of murine adenosine deaminase at pH 6.0
49. Hemolytic reactions mechanically induced by kinked hemodialysis lines
50. Injured erythrocytes release adenosine deaminase into the circulation
51. Isozymes of adenosine deaminase
52. Enzymatic and extra-enzymatic role of acto-adenosine deaminase in lymphocytes
53. Human adenosine deaminase. Distribution and properties
54. Cell surface adenosine deaminase much more than an ectoenzyme
55. Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency
56. Adenosine deaminase isoenzymes and HIV/HTLV-1 infections
57. Structure-activity relationship of ligands of human plasma adenosine deaminase
58. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts
59. Adenosine deaminase from human thyroid purification and some properties
60. Ecto-enzyme activity of human erythrocytes adenosine deaminase
61. Hereditary hemolytic anemia with increased red cell adenosine deaminase (45 to 70 fold) and decreased ATP
62. Adenosine deaminase deficiency in adults
63. Structural and kinetic alterations in adenosine deaminase associated with the differentiation of rat intestinal cells
64. Enzymes of purines metabolism in human peripheral lymphocyte subpopulations
65. Accumulation and salvage of adenosine and inosine by isolated mature cardiac myocytes
66. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma
67. The isolation and characterization of saccharomyces mutants that constitutively express purine biosynthesis
68. Purine pathway enzymes in a cyst forming strain of toxoplasma gondii
69. Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis
70. Metabolisme des nucleotides
71. Oxygen status during hemodialysis. The cord group
72. Effects of hemodialysis on activation of lymphocytes: Analysis by an in vitro dialysis model
73. Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes
74. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CDR3 complex
75. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes
76. Gamma-interferon induced by S aureus protein A augments natural killing and ADCC
77. 2′deoxycoformycin and deoxyadenosine affect IL2 production and IL2 receptor expression of human T cells